Home > Programme

SYNOPSIS

Artificial Intelligence in Action: CVS.AI’s Approach to Addressing Heart Disease

Dr Lohendran Baskaran (National Heart Centre Singapore)

Cardiovascular disease (CVD) remains a leading cause of death and morbidity in Singapore, driven by an ageing population and lifestyle-related risk factors. Early and accurate diagnosis is essential to improving outcomes, and cardiac imaging plays a critical role.

CVS.AI recognises the growing burden of CVD and its impact on public health. It harnesses the power of artificial intelligence to enhance cardiac imaging and support timely, data-driven clinical decisions. By integrating AI with imaging technologies, diagnostic accuracy, efficiency, and patient care are improved.

This talk elaborates on CVS.AI’s ongoing projects and innovations towards transforming cardiovascular care in Singapore and globally.

Reimagining Cardiac Rehabilitation and Prevention:

Thinking Outside the Box

Thank you for making the SPCRS 2025 a success!​

​We couldn’t have done it without you!​​

To our distinguished speakers and abstract presenters, thank you for sharing your expertise, insights and groundbreaking work, which benefited all participants from the healthcare and allied health professions.​

​To our presentation judges, we are truly grateful for your thoughtful evaluations and dedication to upholding excellence in scientific exchange in a world shaped by complexity, rapid change and growing demands.​

​To our sponsors, your generous support made it possible to drive the next leap forward by bringing together a vibrant community of clinicians, researchers and innovators to exploring innovations relevant to preventive cardiology and cardiac rehabilitation.​

​And to all participants, thank you for your active participation. You inspired everyone at the SPCRS 2025 to rethink how we should deliver cardiovascular care in an ever-changing world.​

​SPCRS 2025 may have concluded, but the conversations and connections will go a long way to inspire innovation.​

We look forward to seeing all of you again in 2027!​